Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NICOLa Study: Niacin for Elevated Lipoprotein(a)
2006-005710-12Phase 4Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in lipoprotein(a) hyperlipoproteinemia (Lp(a)), coronary arteriosclerosis, cerebrovascular disease and 1 more comparing Niacin with Placebo (2 arms). Primary endpoints: Cardiovascular event reduction and Change in lipoprotein(a) levels. Started Jun 2007; status: terminated.
02
Drugs
niacin
03
Conditions
lipoprotein(a) hyperlipoproteinemia (Lp(a))coronary arteriosclerosiscerebrovascular diseasearteriosclerosis obliterans
Beyond the preview
Go deeper on 2006-005710-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005710-12.